Offshore
Photo
The Few Bets That Matter
$LULU is in the sweet spot right now. The perfect opportunity.
Clear double bottom. Back above the key averages.
Trendline break. Now filling the earnings gap after the CEO change announcement.
If you believe $LULU can fix Western growth, this is a ~$300 stock over the next 6 months. If they can’t, not much happens.
I shared two detailed write-ups on my Substack covering the narrative, data, and the trade plan.
Link in bio.
tweet
$LULU is in the sweet spot right now. The perfect opportunity.
Clear double bottom. Back above the key averages.
Trendline break. Now filling the earnings gap after the CEO change announcement.
If you believe $LULU can fix Western growth, this is a ~$300 stock over the next 6 months. If they can’t, not much happens.
I shared two detailed write-ups on my Substack covering the narrative, data, and the trade plan.
Link in bio.
$LULU is giving the $190 retest I talked about a month and a half ago.
The bull case hasn’t changed.
Valuation is very low with an accelerating international growth, despite some issues in the West.
If $LULU fixes those Western mismatch problems, after confirming buyers show up and have money to spend, the repricing could happen real fast once the market sees the upside.
We're looking at a move comparable to $VSCO or $AEO. tweet
Offshore
Photo
The Few Bets That Matter
$MRNA is exploding.
And they say you cannot time the market... https://t.co/fieL2u4wZ0
tweet
$MRNA is exploding.
And they say you cannot time the market... https://t.co/fieL2u4wZ0
$MRNA is ready to blow up. And no one is talking about it.
The only one I saw mentionning the name was @nataninvesting since months, bit early to my taste but by now... It's close to perfection.
Liquidity continues to rotate. It really seems to be time to start looking away from tech... Big time. tweet
Offshore
Video
Quiver Quantitative
Republican Representative James Comer: "Nobody on our side is defending Pam Bondi, I can assure you" https://t.co/rLfOLkocVy
tweet
Republican Representative James Comer: "Nobody on our side is defending Pam Bondi, I can assure you" https://t.co/rLfOLkocVy
tweet
Offshore
Video
God of Prompt
RT @godofprompt: SoftBank just bet $70M that your competitors are about to build better software than you.
In 45 days, Emergent jumped from $25M to $50M ARR.
5M+ builders already moved.
6M+ real apps shipped.
While you're debugging Supabase, they're already deployed. https://t.co/ekFZPDYOtf
tweet
RT @godofprompt: SoftBank just bet $70M that your competitors are about to build better software than you.
In 45 days, Emergent jumped from $25M to $50M ARR.
5M+ builders already moved.
6M+ real apps shipped.
While you're debugging Supabase, they're already deployed. https://t.co/ekFZPDYOtf
tweet
Wasteland Capital
At some point relatively soon we will be able to say “Make me a new Lord of the Rings movie, in Studio Ghibli style, James Gunn directing, add a dragon battle”. And then the AI spits out the movie 5 min later.
Personalised media will be brutal for media co’s and Hollywood.
tweet
At some point relatively soon we will be able to say “Make me a new Lord of the Rings movie, in Studio Ghibli style, James Gunn directing, add a dragon battle”. And then the AI spits out the movie 5 min later.
Personalised media will be brutal for media co’s and Hollywood.
tweet
Offshore
Photo
The Few Bets That Matter
The market needs OpenAI to succeed. And if you believe they won't, then you should not own any AI stock.
A lot of people want it to fail but if it does: the market crashes. Interesting paradox.
$ORCL RPOs get cut in half or worse. That flows straight into lower hardware demand for $NVDA, $TSM etc, and growth expectations are destroyed.
OpenAI has to succeed.
Anything less puts serious stress on the market.
tweet
The market needs OpenAI to succeed. And if you believe they won't, then you should not own any AI stock.
A lot of people want it to fail but if it does: the market crashes. Interesting paradox.
$ORCL RPOs get cut in half or worse. That flows straight into lower hardware demand for $NVDA, $TSM etc, and growth expectations are destroyed.
OpenAI has to succeed.
Anything less puts serious stress on the market.
OpenAI is doomed.
They have already lost the enterprise market to Anthropic and I don’t see why they wouldn’t lose the consumer market to Gemini as well.
They don’t have the best product, they don’t have the most money, and they lost top talent to others.
How can they win? https://t.co/BXA8zX8FbO tweet
Offshore
Photo
The Few Bets That Matter
$NVO & $LULU are stocks I’ve been tracking for months; both are now giving the opportunity I was waiting for.
Question is... which one to buy?
$NVO is the safer play. It’s a healthcare name with clear growth potential and the market loves healthcare lately. The Wegovy pill could see massive demand & the stock is trading at historical lows relative to its potential - which still hasn’t shown up in the numbers.
$LULU is the riskier bet. It requires a growth in Western consumption which isn’t guaranteed in today's environment... But $AEO & $VSCO did it and management was clear: demand is here, execution was the issue. Valuation is extremely low, international growth is massive and there’s a clear plan to re-accelerate growth in the West.
Patience is the hardest part of investing. But when two setups you’ve been waiting on for months trigger at the same time, capital allocation becomes the hard part.
Buying too early creates psychological pressure. Buying too late caps returns. The sweet spot, where risk, valuation, and timing align is rare, hard to identify, and even harder to execute.
Right now, both setups are offering that opportunity.
tweet
$NVO & $LULU are stocks I’ve been tracking for months; both are now giving the opportunity I was waiting for.
Question is... which one to buy?
$NVO is the safer play. It’s a healthcare name with clear growth potential and the market loves healthcare lately. The Wegovy pill could see massive demand & the stock is trading at historical lows relative to its potential - which still hasn’t shown up in the numbers.
$LULU is the riskier bet. It requires a growth in Western consumption which isn’t guaranteed in today's environment... But $AEO & $VSCO did it and management was clear: demand is here, execution was the issue. Valuation is extremely low, international growth is massive and there’s a clear plan to re-accelerate growth in the West.
Patience is the hardest part of investing. But when two setups you’ve been waiting on for months trigger at the same time, capital allocation becomes the hard part.
Buying too early creates psychological pressure. Buying too late caps returns. The sweet spot, where risk, valuation, and timing align is rare, hard to identify, and even harder to execute.
Right now, both setups are offering that opportunity.
tweet